Tempest Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 08/14/2026 | 511.29 K | $567.53 K | 2,763.38% | 3.36% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 233.89 K | $259.62 K | 0.00% | 1.54% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 86.63 K | $96.16 K | -0.42% | 0.57% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 68.91 K | $76.49 K | 0.00% | 0.45% |
| BLACKROCK, INC. | 08/07/2026 | 39.07 K | $43.37 K | 0.00% | 0.26% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 30.90 K | $34.30 K | 100.00% | 0.20% |
| NORTHERN TRUST CORP | 08/13/2026 | 20.14 K | $22.35 K | 43.29% | 0.13% |
| CITADEL ADVISORS LLC | 09/02/2026 | 19.82 K | $22.00 K | 100.00% | 0.13% |
| UBS GROUP AG | 08/13/2026 | 5.64 K | $6.26 K | 24.33% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 3.92 K | $4.35 K | 40.57% | 0.03% |
| MORGAN STANLEY | 08/13/2026 | 2.02 K | $2.24 K | -1.75% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 1.51 K | $1.67 K | -1.05% | 0.01% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2026 | 292 | $324 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 239 | $258 | 0.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 222 | $246 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 56 | $62 | 0.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 08/05/2026 | 18 | $20 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 3 | $3 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 3 | $3 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Tempest Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Tempest Therapeutics Inc. The most heavily invested institutionals were:
SABBY MANAGEMENT, LLC: 511,286
VANGUARD CAPITAL MANAGEMENT LLC: 233,888
GEODE CAPITAL MANAGEMENT, LLC: 86,625
VANGUARD FIDUCIARY TRUST CO: 68,908
BlackRock, Inc.: 39,068
Squarepoint Ops LLC: 30,900
6.73% of Tempest Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 1.74 M shares in the last 24 months. This purchase volume represents approximately $4.15 M in transactions.